%PDF-1.6
%
1 0 obj
<>
endobj
2 0 obj
<>stream
Daniel I. Bromage, Stasa Taferner, Mahesh Pillai, Derek M. Yellon, Sean M. Davidson
A novel recombinant antibody specific to full-length stromal derived factor-1 for potential application in biomarker studies
www.plosone.org
www.plosone.org
endstream
endobj
3 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 13 0 R/Annots 14 0 R/Contents 15 0 R/TrimBox[0 0 612 792]>>
endobj
14 0 obj
[16 0 R 17 0 R 18 0 R 19 0 R 20 0 R 21 0 R 22 0 R 23 0 R 24 0 R 25 0 R 26 0 R 27 0 R 28 0 R 29 0 R 30 0 R 31 0 R 32 0 R 33 0 R 34 0 R 35 0 R 36 0 R 37 0 R 38 0 R]
endobj
16 0 obj
<>/Border[0 0 0]/Dest(Rpone.0174447.ref001)>>
endobj
17 0 obj
<>/Border[0 0 0]/Dest(Rpone.0174447.ref005)>>
endobj
18 0 obj
<>/Border[0 0 0]/Dest(Rpone.0174447.ref006)>>
endobj
19 0 obj
<>/Border[0 0 0]/Dest(Rpone.0174447.ref009)>>
endobj
20 0 obj
<>/Border[0 0 0]/Dest(Rpone.0174447.ref010)>>
endobj
21 0 obj
<>/Border[0 0 0]/Dest(Rpone.0174447.ref011)>>
endobj
22 0 obj
<>/Border[0 0 0]/Dest(Rpone.0174447.ref012)>>
endobj
23 0 obj
<>/Border[0 0 0]/Dest(Rpone.0174447.ref013)>>
endobj
24 0 obj
<>/Border[0 0 0]/Dest(Rpone.0174447.ref016)>>
endobj
25 0 obj
<>/Border[0 0 0]/Dest(Rpone.0174447.ref017)>>
endobj
26 0 obj
<>/Border[0 0 0]/Dest(Rpone.0174447.ref018)>>
endobj
27 0 obj
<>/Border[0 0 0]/Dest(Rpone.0174447.ref019)>>
endobj
28 0 obj
<>/Border[0 0 0]/Dest(Rpone.0174447.ref020)>>
endobj
29 0 obj
<>/Border[0 0 0]/Dest(Rpone.0174447.ref012)>>
endobj
30 0 obj
<>/Border[0 0 0]/Dest(Rpone.0174447.ref021)>>
endobj
31 0 obj
<>/Border[0 0 0]/Dest(Rpone.0174447.ref022)>>
endobj
32 0 obj
<>/Border[0 0 0]/Dest(Rpone.0174447.ref023)>>
endobj
33 0 obj
<>/Border[0 0 0]/Dest(Rpone.0174447.ref021)>>
endobj
34 0 obj
<>/Border[0 0 0]/Dest(Rpone.0174447.ref024)>>
endobj
35 0 obj
<>/Border[0 0 0]/Dest(Rpone.0174447.g001)>>
endobj
36 0 obj
<>/Border[0 0 0]/Dest(Rpone.0174447.ref025)>>
endobj
37 0 obj
<>/Border[0 0 0]/Dest(Rpone.0174447.ref026)>>
endobj
38 0 obj
<>/Border[0 0 0]/A 39 0 R>>
endobj
39 0 obj
<>
endobj
15 0 obj
[40 0 R 41 0 R 42 0 R 43 0 R 44 0 R 45 0 R 46 0 R 47 0 R 48 0 R 49 0 R 50 0 R 51 0 R 52 0 R 53 0 R 54 0 R 55 0 R 56 0 R 57 0 R 58 0 R 59 0 R 60 0 R 61 0 R 62 0 R 63 0 R 64 0 R]
endobj
40 0 obj
<>stream
q
0.83 0.64 0.02 0 k
554.6835 674.9858 m
559.4457 674.9858 l
h
f*
564.6047 674.9858 m
569.3669 674.9858 l
h
f*
533.4236 610.0157 m
538.1858 610.0157 l
h
f*
543.3449 610.0157 m
548.1071 610.0157 l
h
f*
412.4409 596.9764 m
421.9654 596.9764 l
h
f*
350.7024 571.011 m
360.2268 571.011 l
h
f*
364.6488 571.011 m
374.1732 571.011 l
h
f*
290.3244 519.0236 m
299.8488 519.0236 l
h
f*
305.0079 519.0236 m
314.5323 519.0236 l
h
f*
386.589 519.0236 m
396.0567 519.0236 l
h
f*
455.6409 519.0236 m
465.1654 519.0236 l
h
f*
268.3276 505.9843 m
277.852 505.9843 l
h
f*
474.8598 505.9843 m
484.3843 505.9843 l
h
f*
556.4976 466.9795 m
566.022 466.9795 l
h
f*
375.3638 441.0142 m
384.8882 441.0142 l
h
f*
334.3748 414.9921 m
343.8992 414.9921 l
h
f*
272.9197 402.0094 m
282.4441 402.0094 l
h
f*
203.4142 375.9874 m
212.9386 375.9874 l
h
f*
217.3606 375.9874 m
226.885 375.9874 l
h
f*
244.2331 363.0047 m
263.7921 363.0047 l
h
f*
231.5906 81.9213 m
241.115 81.9213 l
h
f*
245.537 81.9213 m
255.0614 81.9213 l
h
f*
0 g
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 706.0535 cm
BT
/F2 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Introduction)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 689.1023 cm
BT
/F7 1 Tf
1 TL
-0.004 Tc
0 0 Td
(Stromal)Tj
3.3732 0 Td
(derived)Tj
3.2144 0 Td
(factor-1)Tj
/F11 1 Tf
()Tj
/F7 1 Tf
3.9345 0 Td
(\(SDF-1)Tj
/F11 1 Tf
()Tj
/F7 1 Tf
(/CXCL12\))Tj
7.8349 0 Td
(is)Tj
0.8504 0 Td
(a)Tj
0.652 0 Td
(CXC)Tj
2.1996 0 Td
(chemokine)Tj
4.6545 0 Td
(that)Tj
1.7801 0 Td
(is)Tj
0.8504 0 Td
(expressed)Tj
4.0932 0 Td
(in)Tj
1.0375 0 Td
(several)Tj
-34.4747 -1.3039 Td
(tissues)Tj
2.8176 0 Td
(in)Tj
1.0374 0 Td
(response)Tj
3.7304 0 Td
(to)Tj
1.0261 0 Td
(hypoxia,)Tj
3.617 0 Td
(via)Tj
1.3777 0 Td
(up-regulation)Tj
5.7032 0 Td
(of)Tj
1.0148 0 Td
(hypoxia)Tj
3.3959 0 Td
(inducible)Tj
3.9572 0 Td
(fator-1)Tj
/F11 1 Tf
()Tj
/F7 1 Tf
3.5149 0 Td
(\(HIF-1)Tj
/F11 1 Tf
()Tj
/F7 1 Tf
(\).[)Tj
0.83 0.64 0.02 0 k
(1)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
(5)Tj
0 g
(])Tj
-31.1922 -1.2982 Td
(For)Tj
1.627 0 Td
(example,)Tj
3.7701 0 Td
(SDF-1)Tj
/F11 1 Tf
()Tj
/F7 1 Tf
3.3562 0 Td
(is)Tj
0.8504 0 Td
(up-regulated)Tj
5.3347 0 Td
(in)Tj
1.0318 0 Td
(experimental)Tj
5.4595 0 Td
(and)Tj
1.7292 0 Td
(clinical)Tj
3.0784 0 Td
(studies)Tj
2.9877 0 Td
(of)Tj
1.0148 0 Td
(acute)Tj
2.3244 0 Td
(myocardial)Tj
-32.5642 -1.2983 Td
(infarction)Tj
4.1725 0 Td
(\(MI\),)Tj
2.3584 0 Td
(wherein)Tj
3.4639 0 Td
(it)Tj
0.7881 0 Td
(is)Tj
0.8447 0 Td
(thought)Tj
3.3732 0 Td
(to)Tj
1.0261 0 Td
(mitigate)Tj
3.4923 0 Td
(adverse)Tj
3.2145 0 Td
(ventricular)Tj
4.5864 0 Td
(remodelling.)Tj
5.2951 0 Td
(Its)Tj
1.2189 0 Td
(mecha-)Tj
-33.8341 -1.3039 Td
(nism)Tj
2.2166 0 Td
(of)Tj
1.0148 0 Td
(action)Tj
2.6986 0 Td
(is)Tj
0.8447 0 Td
(reportedly)Tj
4.3653 0 Td
(as)Tj
1.0148 0 Td
(a)Tj
0.652 0 Td
(chemo-attractant)Tj
7.1092 0 Td
(for)Tj
1.389 0 Td
(a)Tj
0.652 0 Td
(variety)Tj
2.9253 0 Td
(of)Tj
1.0148 0 Td
(cell)Tj
1.5591 0 Td
(types)Tj
2.2733 0 Td
(expressing)Tj
4.422 0 Td
(its)Tj
1.1509 0 Td
(cog-)Tj
-35.3024 -1.2983 Td
(nate)Tj
1.9218 0 Td
(G)Tj
0.9355 0 Td
(protein-coupled)Tj
6.6783 0 Td
(receptor,)Tj
3.7814 0 Td
(CXCR4,)Tj
3.5206 0 Td
(including)Tj
4.0422 0 Td
(mesenchymal)Tj
5.7033 0 Td
(stem)Tj
2.1203 0 Td
(cells)Tj
1.9219 0 Td
(\(MSCs\),)Tj
3.5206 0 Td
(adipose-)Tj
-34.1459 -1.2982 Td
(derived)Tj
3.2144 0 Td
(regenerative)Tj
5.125 0 Td
(cells,)Tj
2.143 0 Td
(c-kit)Tj
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 323.2062 615.5149 cm
BT
/F7 1 Tf
1 TL
-0.0053 Tc
0 0 Td
(+)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 329.7826 611.0929 cm
BT
/F7 1 Tf
1 TL
-0.004 Tc
0 0 Td
(endogenous)Tj
5.0569 0 Td
(cardiac)Tj
3.1011 0 Td
(stem)Tj
2.1203 0 Td
(cells)Tj
1.9219 0 Td
(and)Tj
1.7291 0 Td
(T)Tj
0.8334 0 Td
(lymphocytes,[)Tj
0.83 0.64 0.02 0 k
(6)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
(9)Tj
0 g
(])Tj
-27.7396 -1.3039 Td
(which)Tj
2.6476 0 Td
(subsequently)Tj
5.4084 0 Td
(have)Tj
2.058 0 Td
(beneficial)Tj
4.0477 0 Td
(paracrine)Tj
4.0139 0 Td
(effects.[)Tj
0.83 0.64 0.02 0 k
(10)Tj
0 g
(])Tj
4.5807 0 Td
(It)Tj
0.8561 0 Td
(has)Tj
1.542 0 Td
(also)Tj
1.7688 0 Td
(been)Tj
2.126 0 Td
(implicated)Tj
4.4447 0 Td
(in)Tj
1.0318 0 Td
(acute)Tj
-34.5257 -1.2982 Td
(cardioprotection)Tj
6.9108 0 Td
(via)Tj
1.3777 0 Td
(its)Tj
1.1452 0 Td
(binding)Tj
3.3505 0 Td
(to)Tj
1.026 0 Td
(myocardial)Tj
4.7055 0 Td
(CXCR4)Tj
3.2939 0 Td
(and)Tj
1.7347 0 Td
(subsequent)Tj
4.6999 0 Td
(activation)Tj
4.1555 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4684 0 Td
(reper-)Tj
-34.8829 -1.2983 Td
(fusion)Tj
2.7156 0 Td
(injury)Tj
2.6475 0 Td
(salvage)Tj
3.0388 0 Td
(kinase)Tj
2.7495 0 Td
(pathway.[)Tj
0.83 0.64 0.02 0 k
(11)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
5.312 0 Td
(12)Tj
0 g
(])Tj
-15.2672 -1.2983 Td
(Consequent)Tj
5.0287 0 Td
(upon)Tj
2.3244 0 Td
(this)Tj
1.6724 0 Td
(mechanism,)Tj
5.0682 0 Td
(SDF-1)Tj
/F11 1 Tf
()Tj
/F7 1 Tf
3.3562 0 Td
(has)Tj
1.542 0 Td
(been)Tj
2.126 0 Td
(evaluated)Tj
3.9855 0 Td
(as)Tj
1.0148 0 Td
(a)Tj
0.6576 0 Td
(potential)Tj
3.7587 0 Td
(biomarker)Tj
4.4164 0 Td
(in)Tj
-36.1471 -1.3039 Td
(several)Tj
2.931 0 Td
(cardiovascular)Tj
6.0038 0 Td
(contexts,)Tj
3.77 0 Td
(including)Tj
4.0421 0 Td
(both)Tj
2.0636 0 Td
(as)Tj
1.0148 0 Td
(a)Tj
0.652 0 Td
(predictor)Tj
3.9288 0 Td
(of)Tj
1.0148 0 Td
(incident)Tj
3.5206 0 Td
(cardiovascular)Tj
6.0037 0 Td
(events)Tj
-34.9452 -1.2982 Td
(and)Tj
1.7291 0 Td
(of)Tj
1.0148 0 Td
(adverse)Tj
3.2145 0 Td
(outcome.)Tj
3.9515 0 Td
(Specifically,)Tj
4.9151 0 Td
(studies)Tj
2.9821 0 Td
(have)Tj
2.0636 0 Td
(investigated)Tj
4.9889 0 Td
(SDF-1)Tj
/F11 1 Tf
()Tj
/F7 1 Tf
3.3562 0 Td
(in)Tj
1.0318 0 Td
(MI)Tj
1.457 0 Td
(with)Tj
1.9956 0 Td
(and)Tj
1.7291 0 Td
(without)Tj
-34.4293 -1.2983 Td
(ST)Tj
1.304 0 Td
(segment)Tj
3.5602 0 Td
(elevation,[)Tj
0.83 0.64 0.02 0 k
(13)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
(16)Tj
0 g
(])Tj
7.149 0 Td
(cardiac)Tj
3.101 0 Td
(surgery,[)Tj
0.83 0.64 0.02 0 k
(17)Tj
0 g
(])Tj
5.0513 0 Td
(heart)Tj
2.2733 0 Td
(failure,[)Tj
0.83 0.64 0.02 0 k
(18)Tj
0 g
(])Tj
4.6375 0 Td
(patients)Tj
3.3675 0 Td
(at)Tj
0.9525 0 Td
(increased)Tj
4.0025 0 Td
(car-)Tj
-35.3988 -1.3039 Td
(diovascular)Tj
4.7735 0 Td
(risk,[)Tj
0.83 0.64 0.02 0 k
(19)Tj
0 g
(])Tj
3.5717 0 Td
(and)Tj
1.7291 0 Td
(in)Tj
1.0375 0 Td
(relation)Tj
3.3164 0 Td
(to)Tj
1.0261 0 Td
(human)Tj
3.0784 0 Td
(heart)Tj
2.2734 0 Td
(transplantation.[)Tj
0.83 0.64 0.02 0 k
(20)Tj
0 g
(])Tj
8.1864 0 Td
(Similarly,)Tj
4.0308 0 Td
(remote)Tj
-33.0233 -1.2983 Td
(ischaemic)Tj
4.1669 0 Td
(conditioning)Tj
5.3972 0 Td
(\(RIC\),)Tj
2.7495 0 Td
(a)Tj
0.652 0 Td
(technique)Tj
4.1668 0 Td
(of)Tj
1.0148 0 Td
(cyclical,)Tj
3.3619 0 Td
(non-injurious)Tj
5.811 0 Td
(ischaemia)Tj
4.1782 0 Td
(applied)Tj
3.1521 0 Td
(to)Tj
1.0261 0 Td
(an)Tj
-35.6765 -1.2983 Td
(organ)Tj
2.5455 0 Td
(or)Tj
1.0999 0 Td
(tissue)Tj
2.4547 0 Td
(remote)Tj
3.0671 0 Td
(from)Tj
2.2054 0 Td
(the)Tj
1.4683 0 Td
(heart,)Tj
2.5 0 Td
(has)Tj
1.5421 0 Td
(been)Tj
2.1203 0 Td
(reported)Tj
3.6623 0 Td
(by)Tj
1.1792 0 Td
(us)Tj
1.1112 0 Td
(and)Tj
1.7291 0 Td
(others)Tj
2.7099 0 Td
(to)Tj
1.0261 0 Td
(increase)Tj
3.4696 0 Td
(SDF-1)Tj
/F11 1 Tf
()Tj
/F7 1 Tf
-33.8907 -1.3039 Td
(as)Tj
1.0148 0 Td
(measured)Tj
4.1046 0 Td
(using)Tj
2.3924 0 Td
(commercially)Tj
5.6578 0 Td
(available)Tj
3.6623 0 Td
(ELISA)Tj
2.829 0 Td
(kits)Tj
1.6441 0 Td
(\(typically)Tj
3.9004 0 Td
(from)Tj
2.2054 0 Td
(R&D)Tj
2.2847 0 Td
(Systems,)Tj
3.6396 0 Td
(UK\).[)Tj
0.83 0.64 0.02 0 k
(12)Tj
0 g
(])Tj
-32.1389 -1.2982 Td
(SDF-1)Tj
2.7893 0 Td
(is)Tj
0.8447 0 Td
(cleaved)Tj
3.1578 0 Td
(by)Tj
1.1792 0 Td
(several)Tj
2.9367 0 Td
(peptidases,)Tj
4.575 0 Td
(including)Tj
4.0422 0 Td
(leukocyte)Tj
4.0195 0 Td
(elastase,)Tj
3.4242 0 Td
(matrix)Tj
2.88 0 Td
(metallopro-)Tj
-31.0448 -1.2983 Td
(teases)Tj
2.5172 0 Td
(1,)Tj
0.9241 0 Td
(2,)Tj
0.9184 0 Td
(3,)Tj
0.9241 0 Td
(9,)Tj
0.9184 0 Td
(13)Tj
1.1735 0 Td
(and)Tj
1.7291 0 Td
(14,)Tj
1.3947 0 Td
(and)Tj
1.7348 0 Td
(cathepsin)Tj
4.0194 0 Td
(G.[)Tj
0.83 0.64 0.02 0 k
(21)Tj
0 g
(])Tj
2.7893 0 Td
(However,)Tj
4.0818 0 Td
(dipeptidyl)Tj
4.2633 0 Td
(peptidase)Tj
3.9912 0 Td
(4)Tj
0.6973 0 Td
(\(DPP4\),)Tj
-32.0766 -1.2983 Td
(which)Tj
2.6476 0 Td
(cleaves)Tj
2.9877 0 Td
(SDF-1)Tj
2.7836 0 Td
(at)Tj
0.9524 0 Td
(its)Tj
1.1509 0 Td
(position)Tj
3.4921 0 Td
(2)Tj
0.6917 0 Td
(proline)Tj
3.1011 0 Td
(residue,)Tj
3.3505 0 Td
(has)Tj
1.542 0 Td
(been)Tj
2.1203 0 Td
(shown)Tj
2.8517 0 Td
(to)Tj
1.0261 0 Td
(be)Tj
1.1452 0 Td
(predominantly)Tj
-29.8429 -1.3039 Td
(responsible)Tj
4.7509 0 Td
(and)Tj
1.7291 0 Td
(is)Tj
0.8504 0 Td
(the)Tj
1.4683 0 Td
(focus)Tj
2.3301 0 Td
(here.[)Tj
0.83 0.64 0.02 0 k
(22)Tj
0 g
(])Tj
3.821 0 Td
(Cleavage)Tj
3.7643 0 Td
(reduces)Tj
3.2769 0 Td
(the)Tj
1.4683 0 Td
(affinity)Tj
3.0671 0 Td
(of)Tj
1.0148 0 Td
(SDF-1)Tj
2.7892 0 Td
(for)Tj
1.3833 0 Td
(CXCR4,)Tj
3.5206 0 Td
(ren-)Tj
-35.2343 -1.2982 Td
(dering)Tj
2.8233 0 Td
(it)Tj
0.7824 0 Td
(inactive.[)Tj
0.83 0.64 0.02 0 k
(23)Tj
0 g
(])Tj
5.193 0 Td
(Currently,)Tj
4.3539 0 Td
(commercial)Tj
4.9549 0 Td
(antibodies)Tj
4.3597 0 Td
(have)Tj
2.0636 0 Td
(different)Tj
3.651 0 Td
(affinities)Tj
3.6623 0 Td
(towards)Tj
3.4073 0 Td
(intact)Tj
-35.2514 -1.2983 Td
(SDF-1)Tj
/F11 1 Tf
()Tj
/F7 1 Tf
3.3562 0 Td
(\(consisting)Tj
4.6035 0 Td
(of)Tj
1.0148 0 Td
(amino)Tj
2.8006 0 Td
(acids)Tj
2.2279 0 Td
(167\))Tj
2.5058 0 Td
(and)Tj
1.7291 0 Td
(DPP4-truncated)Tj
6.7578 0 Td
(SDF-1)Tj
/F11 1 Tf
()Tj
/F7 1 Tf
3.3505 0 Td
(\(amino)Tj
3.1408 0 Td
(acids)Tj
2.2337 0 Td
(367\),)Tj
-33.7207 -1.3039 Td
([)Tj
0.83 0.64 0.02 0 k
(21)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
1.7348 0 Td
(24)Tj
0 g
(])Tj
1.5137 0 Td
(and)Tj
1.7291 0 Td
(the)Tj
1.4684 0 Td
(kinetics)Tj
3.3051 0 Td
(of)Tj
1.0148 0 Td
(full-length,)Tj
4.6147 0 Td
(active)Tj
2.5228 0 Td
(SDF-1)Tj
/F11 1 Tf
()Tj
/F7 1 Tf
3.3562 0 Td
(in)Tj
1.0318 0 Td
(response)Tj
3.7361 0 Td
(to)Tj
1.0261 0 Td
(tissue)Tj
2.4548 0 Td
(hypoxia)Tj
3.3959 0 Td
(are)Tj
-32.9043 -1.2983 Td
(unknown)Tj
4.0819 0 Td
(\()Tj
0.83 0.64 0.02 0 k
(Fig)Tj
1.8198 0 Td
(1)Tj
0 g
(\).)Tj
1.2586 0 Td
(Analysis)Tj
3.5773 0 Td
(is)Tj
0.8504 0 Td
(complicated)Tj
5.1079 0 Td
(by)Tj
1.1792 0 Td
(the)Tj
1.4683 0 Td
(absence)Tj
3.3392 0 Td
(of)Tj
1.0148 0 Td
(a)Tj
0.6576 0 Td
(method)Tj
3.3222 0 Td
(to)Tj
1.0262 0 Td
(specifically)Tj
4.5694 0 Td
(quantify)Tj
-33.2728 -1.2983 Td
(active)Tj
2.5172 0 Td
(SDF-1)Tj
/F11 1 Tf
()Tj
/F7 1 Tf
3.3562 0 Td
(in)Tj
1.0374 0 Td
(plasma.)Tj
3.2599 0 Td
(We)Tj
1.6044 0 Td
(therefore)Tj
3.855 0 Td
(aimed)Tj
2.6929 0 Td
(to)Tj
1.0261 0 Td
(develop)Tj
3.3222 0 Td
(a)Tj
0.6519 0 Td
(method)Tj
3.3222 0 Td
(to)Tj
1.0262 0 Td
(investigate)Tj
4.4617 0 Td
(intact)Tj
2.4888 0 Td
(SDF-)Tj
-34.6221 -1.3039 Td
(1)Tj
/F11 1 Tf
()Tj
/F7 1 Tf
(,)Tj
1.491 0 Td
(using)Tj
2.3868 0 Td
(RIC)Tj
1.8482 0 Td
(as)Tj
1.0148 0 Td
(an)Tj
1.2019 0 Td
(example.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 308.0125 cm
BT
/F2 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Materials)Tj
4.5071 0 Td
(&)Tj
0.9354 0 Td
(methods)Tj
/F0 1 Tf
-5.4425 -1.4976 Td
(Ethics)Tj
2.9149 0 Td
(statement)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 273.033 cm
BT
/F7 1 Tf
1 TL
-0.004 Tc
0 0 Td
(All)Tj
1.3946 0 Td
(procedures)Tj
4.6771 0 Td
(were)Tj
2.1203 0 Td
(performed)Tj
4.4674 0 Td
(with)Tj
2.0012 0 Td
(Local)Tj
2.3641 0 Td
(Research)Tj
3.8098 0 Td
(Ethics)Tj
2.6645 0 Td
(Committee)Tj
4.7395 0 Td
(approval)Tj
3.702 0 Td
(at)Tj
0.9525 0 Td
(the)Tj
1.4683 0 Td
(Hatter)Tj
-34.3613 -1.2982 Td
(Cardiovascular)Tj
6.2418 0 Td
(Institute,)Tj
3.8097 0 Td
(University)Tj
4.3994 0 Td
(College)Tj
3.1974 0 Td
(London)Tj
3.3959 0 Td
(\(12/0448\).)Tj
4.3087 0 Td
(Experiments)Tj
5.2837 0 Td
(were)Tj
2.126 0 Td
(conducted)Tj
-32.7626 -1.2983 Td
(according)Tj
4.1839 0 Td
(to)Tj
1.0261 0 Td
(the)Tj
1.474 0 Td
(principles)Tj
4.1612 0 Td
(expressed)Tj
4.0932 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
1.4683 0 Td
(Declaration)Tj
4.9096 0 Td
(of)Tj
1.0148 0 Td
(Helsinki.)Tj
3.8211 0 Td
(Volunteers)Tj
4.6204 0 Td
(gave)Tj
2.0013 0 Td
(informed)Tj
-33.8114 -1.3039 Td
(consent.)Tj
3.5546 0 Td
(All)Tj
1.3946 0 Td
(use)Tj
1.5364 0 Td
(of)Tj
1.0148 0 Td
(animals)Tj
3.3278 0 Td
(was)Tj
1.7008 0 Td
(in)Tj
1.0318 0 Td
(accordance)Tj
4.7395 0 Td
(with)Tj
1.9956 0 Td
(the)Tj
1.4683 0 Td
(United)Tj
3.0217 0 Td
(Kingdom)Tj
4.0309 0 Td
(\(Scientific)Tj
4.2406 0 Td
(Proce-)Tj
-33.0574 -1.2983 Td
(dures\))Tj
2.7665 0 Td
(Act)Tj
1.6158 0 Td
(1986.)Tj
2.3414 0 Td
(The)Tj
1.7801 0 Td
(experiments)Tj
5.1307 0 Td
(were)Tj
2.1203 0 Td
(prospectively)Tj
5.4765 0 Td
(approved)Tj
3.9685 0 Td
(by)Tj
1.1735 0 Td
(the)Tj
1.4627 0 Td
(UK)Tj
1.6271 0 Td
(Home)Tj
2.7326 0 Td
(Office)Tj
2.6475 0 Td
(animal)Tj
-34.8432 -1.2982 Td
(research)Tj
3.5546 0 Td
(ethics)Tj
2.5228 0 Td
(committee)Tj
4.5014 0 Td
(under)Tj
2.6192 0 Td
(Project)Tj
3.0557 0 Td
(Licence)Tj
3.2712 0 Td
(number)Tj
3.4129 0 Td
(PPL)Tj
1.8765 0 Td
(70/8556,)Tj
3.6283 0 Td
(\(Protection)Tj
5.159 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
-34.6164 -1.3039 Td
(Ischaemic)Tj
4.2406 0 Td
(and)Tj
1.7291 0 Td
(Reperfused)Tj
4.7055 0 Td
(Myocardium\))Tj
6.1738 0 Td
(issued)Tj
2.6929 0 Td
(to)Tj
1.0204 0 Td
(Prof.)Tj
2.1714 0 Td
(Derek)Tj
2.6702 0 Td
(Yellon)Tj
2.8289 0 Td
(in)Tj
1.0318 0 Td
(2015.)Tj
2.3471 0 Td
(Adult)Tj
2.5058 0 Td
(male)Tj
-34.1175 -1.2983 Td
(Sprague-Dawley)Tj
6.7634 0 Td
(rats)Tj
1.6837 0 Td
(weighing)Tj
3.8665 0 Td
(200250)Tj
3.5943 0 Td
(g)Tj
0.686 0 Td
(\(Harlan)Tj
3.3618 0 Td
(Laboratories,)Tj
5.4652 0 Td
(UK\))Tj
1.9672 0 Td
(were)Tj
2.1203 0 Td
(euthanized)Tj
4.6148 0 Td
(by)Tj
1.1792 0 Td
(ter-)Tj
-35.3024 -1.2983 Td
(minal)Tj
2.5341 0 Td
(anaesthesia)Tj
4.7338 0 Td
(with)Tj
1.9956 0 Td
(100)Tj
1.6498 0 Td
(mg/kg)Tj
2.7949 0 Td
(pentobarbitone)Tj
6.3779 0 Td
(sodium)Tj
3.2315 0 Td
(administered)Tj
5.4878 0 Td
(IP.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 139.011 cm
BT
/F0 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Antibody)Tj
4.063 0 Td
(characterisation)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 122.0031 cm
BT
/F7 1 Tf
1 TL
-0.004 Tc
0 0 Td
(A)Tj
0.9014 0 Td
(custom)Tj
3.1577 0 Td
(human)Tj
3.0784 0 Td
(IgG1)Tj
2.2167 0 Td
(bivalent)Tj
3.4016 0 Td
(mini-antibody,)Tj
6.2418 0 Td
(with)Tj
1.9956 0 Td
(embedded)Tj
4.3993 0 Td
(FLAG)Tj
2.6873 0 Td
(octapeptide)Tj
4.8585 0 Td
(and)Tj
-32.9383 -1.2982 Td
(polyhistidine)Tj
5.4311 0 Td
(\(His6\))Tj
2.7723 0 Td
(tags,)Tj
2.0012 0 Td
(was)Tj
1.7008 0 Td
(identified)Tj
4.0592 0 Td
(from)Tj
2.2053 0 Td
(the)Tj
1.4684 0 Td
(HuCAL)Tj
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 428.2015 113.4425 cm
BT
/F12 1 Tf
1 TL
-0.0053 Tc
0 0 Td
(1)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 437.896 109.0204 cm
BT
/F7 1 Tf
1 TL
-0.004 Tc
0 0 Td
(\(Human)Tj
3.6566 0 Td
(Combinatorial)Tj
-27.4447 -1.3039 Td
(Antibody)Tj
4.0138 0 Td
(Library\))Tj
3.5036 0 Td
(phage-display)Tj
5.7429 0 Td
(library)Tj
2.8744 0 Td
(containing)Tj
4.5297 0 Td
(several)Tj
2.931 0 Td
(billion,)Tj
3.0329 0 Td
(distinct,)Tj
3.4413 0 Td
(fully)Tj
1.9842 0 Td
(human)Tj
3.0728 0 Td
(anti-)Tj
-35.1266 -1.2982 Td
(bodies.[)Tj
0.83 0.64 0.02 0 k
(25)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
4.5524 0 Td
(26)Tj
0 g
(])Tj
1.5137 0 Td
(The)Tj
1.7801 0 Td
(library)Tj
2.8743 0 Td
(was)Tj
1.6951 0 Td
(screened)Tj
3.7247 0 Td
(using)Tj
2.3925 0 Td
(positive)Tj
3.3108 0 Td
(selection)Tj
3.7189 0 Td
(for)Tj
1.389 0 Td
(binding)Tj
3.3505 0 Td
(to)Tj
1.0262 0 Td
(the)Tj
1.4683 0 Td
(peptide)Tj
ET
Q
q
1 j
1 J
0 w
576 737.1 m
36 737.1 l
36 737.6 l
576 737.6 l
f*
36 741.2598 107.1496 23.6976 re
W* n
q
107.0929 0 0 23.6409 36 741.3165 cm
q
/I0 Do
Q
Q
Q
q
0 0 612 792 re
W* n
1 j
1 J
0 w
7.9999 0 0 7.9999 165.5433 745.7952 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(A)Tj
0.8787 0 Td
(novel)Tj
2.5654 0 Td
(recombin)Tj
4.0394 0 Td
(ant)Tj
1.5874 0 Td
(antibody)Tj
3.926 0 Td
(specific)Tj
3.4937 0 Td
(to)Tj
1.0418 0 Td
(full-length)Tj
4.4646 0 Td
(stromal)Tj
3.4441 0 Td
(derived)Tj
3.437 0 Td
(factor-1)Tj
3.5575 0 Td
(for)Tj
1.3678 0 Td
(potentia)Tj
3.4866 0 Td
(l)Tj
0.4323 0 Td
(application)Tj
4.904 0 Td
(in)Tj
0.9779 0 Td
(biomarke)Tj
4.0394 0 Td
(r)Tj
0.5457 0 Td
(studies)Tj
ET
Q
q
1 j
1 J
0 w
36 48.0002 m
576 48.0002 l
576 47.5002 l
36 47.5002 l
f*
0.83 0.64 0.02 0 k
81.5811 34.9228 m
237.8835 34.9228 l
h
f*
0 g
7.9999 0 0 7.9999 36 36 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(PLOS)Tj
2.8559 0 Td
(ONE)Tj
2.3669 0 Td
(|)Tj
0.83 0.64 0.02 0 k
0.4748 0 Td
(https://doi.or)Tj
5.4142 0 Td
(g/10.137)Tj
3.8198 0 Td
(1/journal.po)Tj
5.1236 0 Td
(ne.01744)Tj
4.089 0 Td
(47)Tj
0 g
2.0906 0 Td
(April)Tj
2.1827 0 Td
(5,)Tj
1.0417 0 Td
(2017)Tj
35.6814 0 Td
(2)Tj
0.7654 0 Td
(/)Tj
0.496 0 Td
(16)Tj
/F9 1 Tf
-0.025 Tc
-66.402 84.0904 Td
(proportion)Tj
4.1244 0 Td
(of)Tj
0.9496 0 Td
(funding)Tj
3.0331 0 Td
(from)Tj
2.0126 0 Td
(the)Tj
1.3677 0 Td
(Department)Tj
4.5922 0 Td
(of)Tj
-16.0796 -1.3748 Td
(Health's)Tj
3.189 0 Td
(NIHR)Tj
2.2393 0 Td
(Biomed)Tj
2.8347 0 Td
(ical)Tj
1.4528 0 Td
(Researc)Tj
2.9976 0 Td
(h)Tj
0.6945 0 Td
(Centres)Tj
-13.4079 -1.3749 Td
(funding)Tj
3.033 0 Td
(scheme.)Tj
/F8 1 Tf
-3.033 -2.126 Td
(Competing)Tj
4.3795 0 Td
(interests)Tj
3.3307 0 Td
(:)Tj
/F9 1 Tf
0.4819 0 Td
(The)Tj
1.5875 0 Td
(authors)Tj
3.0401 0 Td
(have)Tj
1.963 0 Td
(declared)Tj
-14.7827 -1.3748 Td
(that)Tj
1.6228 0 Td
(no)Tj
1.1693 0 Td
(competing)Tj
4.1599 0 Td
(interests)Tj
ET
endstream
endobj
41 0 obj
<>stream
endstream
endobj
42 0 obj
<>stream
endstream
endobj
43 0 obj
<>stream
endstream
endobj
44 0 obj
<>stream
endstream
endobj
45 0 obj
<>stream
endstream
endobj
46 0 obj
<>stream
endstream
endobj
47 0 obj
<>stream
endstream
endobj
48 0 obj
<>stream
endstream
endobj
49 0 obj
<>stream
endstream
endobj
50 0 obj
<>stream
endstream
endobj
51 0 obj
<>stream
endstream
endobj
52 0 obj
<>stream
endstream
endobj
53 0 obj
<>stream
endstream
endobj
54 0 obj
<>stream
endstream
endobj
55 0 obj
<>stream
endstream
endobj
56 0 obj
<>stream
endstream
endobj
57 0 obj
<>stream
endstream
endobj
58 0 obj
<>stream
endstream
endobj
59 0 obj
<>stream
endstream
endobj
60 0 obj
<>stream
endstream
endobj
61 0 obj
<>stream
endstream
endobj
62 0 obj
<>stream
endstream
endobj
63 0 obj
<>stream
endstream
endobj
64 0 obj
<>stream
BT
10.3394 77.8399 Td
(exist.)Tj
ET
Q
endstream
endobj
65 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 13 0 R/Annots 69 0 R/Contents 70 0 R/TrimBox[0 0 612 792]>>
endobj
68 0 obj
<>stream
JFIF C
$, !$4.763.22:ASF:=N>22HbINVX]^]8EfmeZlS[]Y C**Y;2;YYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYY "
} !1AQa"q2#BR$3br
%&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz
w !1AQaq"2B #3Rbr
$4%&'()*56789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz ? (
(
(
(
(
(
(
(
(
(
(
(
(
(
(
(
(
(
(
(
(
(
(
(
(
(
(
(
(
(
(
(
(
(
(
(
(
(
(Z((Z%̖4Dp4һyհ]]w#גy
$s#Z7.. w2!=XfhSvowomyеH$(u[ww2F
mmFx D1C.[E-u E- R@ KIK@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@bx@Sbx@S>p
Żc+OaKYzjyQԃAIa --oSWeQEyGQE QE %-%- QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE QE O[uOWODTY )k2=tˈRL5m xWFH(GJ<-ω`]EWzEPEPRREPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPY^$k@5X+vM
}i#T>$Ly1
ZzڝX02֫X\[yC@5M;hyj 9
pkgmu.R_;=_
K$~#QW֊|FI#ԨL( ( JZJZ ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( (̨f
=IQYZm|SYW~8ךG tW~!YZ}샱 7.<â]=28ފ[>"àJK)) 89